By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Iverson Genetic Diagnostics announced a collaboration with Vanderbilt University aimed at molecular diagnostics to assess breast cancer risk in menopausal women.

The test would help physicians assess the risk of breast cancer in women who are considering hormone replacement therapy during menopause.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.